Humedix Co., Ltd.
200670.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
121
Cost of Revenue
65
Gross Profit
56
Gross Margin
46.3%
Operating Income
32
Operating Margin
26.7%
Net Income
29
Net Margin
24.3%
EPS (Basic)
$3.00
EPS (Diluted)
$3.00
EBITDA
45
EBITDA Margin
37.0%
2023
12/31/2023
Revenue
114
Cost of Revenue
61
Gross Profit
53
Gross Margin
46.2%
Operating Income
28
Operating Margin
24.5%
Net Income
19
Net Margin
16.3%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
34
EBITDA Margin
29.6%
2022
12/31/2022
Revenue
92
Cost of Revenue
53
Gross Profit
40
Gross Margin
43.0%
Operating Income
20
Operating Margin
21.1%
Net Income
16
Net Margin
17.1%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
37
EBITDA Margin
39.8%
2021
12/31/2021
Revenue
83
Cost of Revenue
52
Gross Profit
32
Gross Margin
37.9%
Operating Income
12
Operating Margin
14.4%
Net Income
7
Net Margin
8.2%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
23
EBITDA Margin
28.1%
2020
12/31/2020
Revenue
74
Cost of Revenue
45
Gross Profit
29
Gross Margin
38.6%
Operating Income
12
Operating Margin
16.9%
Net Income
11
Net Margin
15.3%
EPS (Basic)
$1.00
EPS (Diluted)
$1.00
EBITDA
23
EBITDA Margin
31.1%